TY - JOUR
T1 - Activation of the retrohippocampal region in the rat causes dopamine release in the nucleus accumbens
T2 - Disruption by fornix section
AU - Mitchell, Stephen N.
AU - Yee, Ben K.
AU - Feldon, Joram
AU - Gray, Jeffrey A.
AU - Rawlins, J. Nick P.
N1 - Funding Information:
The work was supported by a grant from Bristol Myers Squibb.
PY - 2000/10/27
Y1 - 2000/10/27
N2 - There is a well-described projection from the retrohippocampus (subiculum and entorhinal cortex) to the nucleus accumbens that is involved in the control of psychomotor behaviour, and is implicated in the aetiology of schizophrenia. Cortical abnormalities are widely reported in the brains of schizophrenic patients, but it is unclear whether they are the cause or consequence of those changes in subcortical systems that are treated with neuroleptic drugs. We have, therefore, conducted a series of microdialysis experiments in anaesthetized rats to determine whether infusion of the excitotoxin, N-methyl-D-aspartate, into the retrohippocampus increases mesolimbic dopamine release. We found a clear and reproducible increase in extracellular dopamine in the nucleus accumbens following N-methyl-D-aspartate (2.5 μg), that was abolished when we sectioned the fimbria-fornix. Furthermore, inhibition of γ-aminobutyric acid receptors following retrohippocampus administration of bicuculline (4 μg), also increased dopamine in the nucleus accumbens. The dopamine response to bicuculline was accompanied by an increase in dopamine metabolism, was long lasting, and also reduced by fornix section.The response to both N-methyl-D-aspartate and bicuculline depends on the integrity of the projection from the retrohippocampus to the nucleus accumbens. The results provide an underlying mechanism whereby a primary insult in the temporal cortex, caused by excessive N-methyl-D-aspartate receptor stimulation, can produce a hyperdopaminergic state. In addition, an increase in subiculo-accumbens activity evoked by bicuculline may also explain why patients with limbic epilepsy can develop a psychosis. Copyright (C) 2000 Elsevier Science B.V.
AB - There is a well-described projection from the retrohippocampus (subiculum and entorhinal cortex) to the nucleus accumbens that is involved in the control of psychomotor behaviour, and is implicated in the aetiology of schizophrenia. Cortical abnormalities are widely reported in the brains of schizophrenic patients, but it is unclear whether they are the cause or consequence of those changes in subcortical systems that are treated with neuroleptic drugs. We have, therefore, conducted a series of microdialysis experiments in anaesthetized rats to determine whether infusion of the excitotoxin, N-methyl-D-aspartate, into the retrohippocampus increases mesolimbic dopamine release. We found a clear and reproducible increase in extracellular dopamine in the nucleus accumbens following N-methyl-D-aspartate (2.5 μg), that was abolished when we sectioned the fimbria-fornix. Furthermore, inhibition of γ-aminobutyric acid receptors following retrohippocampus administration of bicuculline (4 μg), also increased dopamine in the nucleus accumbens. The dopamine response to bicuculline was accompanied by an increase in dopamine metabolism, was long lasting, and also reduced by fornix section.The response to both N-methyl-D-aspartate and bicuculline depends on the integrity of the projection from the retrohippocampus to the nucleus accumbens. The results provide an underlying mechanism whereby a primary insult in the temporal cortex, caused by excessive N-methyl-D-aspartate receptor stimulation, can produce a hyperdopaminergic state. In addition, an increase in subiculo-accumbens activity evoked by bicuculline may also explain why patients with limbic epilepsy can develop a psychosis. Copyright (C) 2000 Elsevier Science B.V.
KW - Dopamine
KW - Fimbria-fornix
KW - Microdialysis
KW - Nucleus accumbens
KW - Rat
KW - Subiculum
UR - http://www.scopus.com/inward/record.url?scp=0034722001&partnerID=8YFLogxK
U2 - 10.1016/S0014-2999(00)00741-X
DO - 10.1016/S0014-2999(00)00741-X
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0034722001
SN - 0014-2999
VL - 407
SP - 131
EP - 138
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 1-2
ER -